Thermo Fisher Hears B.R.A.H.M.S.
Wade Roush9/3/09
Waltham, MA-based Thermo Fisher Scientific (NYSE: TMO), one of the world’s leading makers of diagnostic devices and lab equipment, said today that it has purchased Hennigsdorf, Germany-based B.R.A.H.M.S. for €330 million (US $470 million). B.R.A.H.M.S. is known for making a line of in vitro diagnostic tests based on patented biomarkers, including a test for sepsis widely used in Europe. A Thermo Fisher spokesperson said the acquisition would complement the company’s existing line of immunoassay testing products and give it “a significant reagent manufacturing footprint in Europe.”
Wade Roush is Xconomy's chief correspondent and editor of Xconomy San Francisco. You can e-mail him at wroush@xconomy.com or follow him on Twitter at twitter.com/wroush.
